person · Reporting owner

Sherbet Eric

Disclosed activity across 2 companies

Tapewire entity: 27492
SEC CIK: 0001679512

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
IQVIA HOLDINGS INC.IQV · Entity 3058	See Remarks	July 29, 2026	July 31, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

IQVIA HOLDINGS INC.

Report date July 29, 2026 · Filed July 31, 2026

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	20,999	Reported balance After 2026-07-29 transaction · row 1 1 source row Row 1 · 2026-07-29 · Sale · Disposed 5,000 · Balance 20,999

Past disclosures · reporting ended (1)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

Patheon N.V.

Report date August 29, 2017 · Filed August 31, 2017

Section 16 reporting ended · disclosed 2017-08-31. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosure context
Restricted Stock Units (Ordinary Shares)SEC Table I · non-derivative	Direct	Ending reported balance After 2017-08-29 transaction · row 2 2 source rows · reconciled sequence Row 1 · 2017-08-29 · Other · Disposed 12,552 · Balance 219,330 F1: Ordinary shares of Patheon N.V. ("Issuer") were disposed of pursuant to a tender offer by Thermo Fisher (CN) Luxembourg S.a r.l., a private limited liability company (societe a responsabilite limitee) organized under the laws of the Grand Duchy of Luxembourg ("Purchaser") and Thermo Fisher Scientific Inc., a Delaware corporation ("Thermo Fisher"), to acquire all of the issued and outstanding ordinary shares (the "Shares") of Issuer at a purchase price of $35.00 per Share, pursuant to the terms of the Purchase Agreement, dated as of May 15, 2017 (as it may be amended from time to time, the "Purchase Agreement"), by and between Issuer, Purchaser and Thermo Fisher. Pursuant to the terms of the Purchase Agreement, each vested restricted stock unit was cancelled and converted into the right to receive an amount in cash, without interest, equal to the product obtained by multiplying $35.00 by the total number of Shares subject to the restricted stock unit (continued in footnote 2) F2: upon the closing of the tender offer (with restricted stock units that are subject to performance conditions vesting based on achievement of actual performance conditions in accordance with the terms of the award). Each unvested restricted stock unit was cancelled and converted into a restricted stock unit award, with substantially the same terms and conditions (including with respect to vesting) as were applicable to such unvested restricted stock unit immediately prior to the closing of the tender offer, with respect to a number of shares of Thermo Fisher common stock equal to the product (rounded to the nearest whole share) obtained by multiplying (x) the Exchange Ratio by (y) the total number of Shares subject to the unvested restricted stock unit as of immediately prior to the closing of the tender offer. (continued in footnote 3) F3: The "Exchange Ratio" is 0.1996919, which represents the quotient obtained by dividing (i) $35.00 by (ii) the average closing price, rounded to the nearest cent, per share of common stock of Thermo Fisher on the NYSE for the consecutive period of ten (10) trading days immediately preceding (but not including) the date of the closing of the tender offer. F4: This amount represents 12,552 unvested restricted stock units, each of which represented a contingent right to receive one Share of Issuer. Each unvested restricted stock unit was cancelled and converted into a restricted stock unit award, with substantially the same terms and conditions (including with respect to vesting) as were applicable to such unvested restricted stock unit immediately prior to the closing of the tender offer, with respect to a number of shares of Thermo Fisher common stock equal to the product (rounded to the nearest whole share) obtained by multiplying (x) the Exchange Ratio by (y) the total number of Shares subject to the unvested restricted stock unit as of immediately prior to the closing of the tender offer. Row 2 · 2017-08-29 · Other · Disposed 219,330 · Balance 0 F5: This amount represents 219,330 outstanding restricted stock unit awards in respect of Shares that were subject, in whole or in part, to vesting based on the achievement of one or more performance goals (each, a "PSU"), whether vested or unvested. Pursuant to the terms of the Purchase Agreement, 111,780 PSUs were automatically cancelled and converted into the right to receive an amount in cash (without interest and subject to required tax withholding), equal to the product of (i) $35.00 multiplied by (ii) the total number of Shares subject to such PSU award as of immediately prior to the closing of the tender offer (which, in the case of PSUs, was determined based on the actual achievement of performance conditions in accordance with the terms of the award). The remaining 107,550 PSUs were automatically cancelled and forfeited for no consideration in accordance with the terms of the Purchase Agreement and the PSU award.
Ordinary SharesSEC Table I · non-derivative	IndirectBy Patheon Holdco Cooperatief U.A. on behalf of the reporting person	Reported balance After 2017-08-29 transaction · row 3 Account identity is unresolved; indirect or unspecified ownership is not merged. 1 source row Row 3 · 2017-08-29 · Other · Disposed 129,595 · Balance 0 F1: Ordinary shares of Patheon N.V. ("Issuer") were disposed of pursuant to a tender offer by Thermo Fisher (CN) Luxembourg S.a r.l., a private limited liability company (societe a responsabilite limitee) organized under the laws of the Grand Duchy of Luxembourg ("Purchaser") and Thermo Fisher Scientific Inc., a Delaware corporation ("Thermo Fisher"), to acquire all of the issued and outstanding ordinary shares (the "Shares") of Issuer at a purchase price of $35.00 per Share, pursuant to the terms of the Purchase Agreement, dated as of May 15, 2017 (as it may be amended from time to time, the "Purchase Agreement"), by and between Issuer, Purchaser and Thermo Fisher. Pursuant to the terms of the Purchase Agreement, each vested restricted stock unit was cancelled and converted into the right to receive an amount in cash, without interest, equal to the product obtained by multiplying $35.00 by the total number of Shares subject to the restricted stock unit (continued in footnote 2) F2: upon the closing of the tender offer (with restricted stock units that are subject to performance conditions vesting based on achievement of actual performance conditions in accordance with the terms of the award). Each unvested restricted stock unit was cancelled and converted into a restricted stock unit award, with substantially the same terms and conditions (including with respect to vesting) as were applicable to such unvested restricted stock unit immediately prior to the closing of the tender offer, with respect to a number of shares of Thermo Fisher common stock equal to the product (rounded to the nearest whole share) obtained by multiplying (x) the Exchange Ratio by (y) the total number of Shares subject to the unvested restricted stock unit as of immediately prior to the closing of the tender offer. (continued in footnote 3) F3: The "Exchange Ratio" is 0.1996919, which represents the quotient obtained by dividing (i) $35.00 by (ii) the average closing price, rounded to the nearest cent, per share of common stock of Thermo Fisher on the NYSE for the consecutive period of ten (10) trading days immediately preceding (but not including) the date of the closing of the tender offer. F6: This amount represents ordinary shares held by Patheon Holdco Cooperatief U.A. on behalf of the reporting person. Such Shares were disposed of by Patheon Holdco Cooperatief U.A. pursuant to the tender offer for $35.00 per Share.
Options (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $26.49	Direct	Reported balance After 2017-08-29 transaction · row 4 Instrument identity requires review; Table II rows are not merged. 1 source row Row 4 · 2017-08-29 · Disposition to issuer · Disposed 32,630 · Balance 0 F7: The terms of the Option awards provide that options vest in three equal installments on each anniversary of the grant date of March 23, 2017. Options were disposed of pursuant to the Purchase Agreement, whereby each vested option was cancelled and converted into the right to receive an amount in cash, without interest, equal to the product of (x) the excess of $35.00 over the per Share exercise price of the option, multiplied by the number of Shares subject to the option upon the closing of the tender offer (rounded down to the nearest whole share). Each unvested option was cancelled and converted into a stock option award, with substantially the same terms and conditions (including with respect to vesting) as were applicable to such unvested option immediately prior to the closing of the tender offer, (i) with respect to a number of shares of Thermo Fisher common stock equal to the product (rounded down to the nearest whole share) obtained by multiplying (x) (continued in footnote 8) F8: the Exchange Ratio by (y) the total number of Shares subject to such unvested option as of immediately prior to the closing of the tender offer and (ii) at an exercise price per share that is equal to the quotient (rounded up to the nearest cent) obtained by dividing (x) the exercise price per share of such unvested option by (y) the Exchange Ratio.

Filing footnotes · ownership attribution and instrument terms

F1: Ordinary shares of Patheon N.V. ("Issuer") were disposed of pursuant to a tender offer by Thermo Fisher (CN) Luxembourg S.a r.l., a private limited liability company (societe a responsabilite limitee) organized under the laws of the Grand Duchy of Luxembourg ("Purchaser") and Thermo Fisher Scientific Inc., a Delaware corporation ("Thermo Fisher"), to acquire all of the issued and outstanding ordinary shares (the "Shares") of Issuer at a purchase price of $35.00 per Share, pursuant to the terms of the Purchase Agreement, dated as of May 15, 2017 (as it may be amended from time to time, the "Purchase Agreement"), by and between Issuer, Purchaser and Thermo Fisher. Pursuant to the terms of the Purchase Agreement, each vested restricted stock unit was cancelled and converted into the right to receive an amount in cash, without interest, equal to the product obtained by multiplying $35.00 by the total number of Shares subject to the restricted stock unit (continued in footnote 2)

F2: upon the closing of the tender offer (with restricted stock units that are subject to performance conditions vesting based on achievement of actual performance conditions in accordance with the terms of the award). Each unvested restricted stock unit was cancelled and converted into a restricted stock unit award, with substantially the same terms and conditions (including with respect to vesting) as were applicable to such unvested restricted stock unit immediately prior to the closing of the tender offer, with respect to a number of shares of Thermo Fisher common stock equal to the product (rounded to the nearest whole share) obtained by multiplying (x) the Exchange Ratio by (y) the total number of Shares subject to the unvested restricted stock unit as of immediately prior to the closing of the tender offer. (continued in footnote 3)

F3: The "Exchange Ratio" is 0.1996919, which represents the quotient obtained by dividing (i) $35.00 by (ii) the average closing price, rounded to the nearest cent, per share of common stock of Thermo Fisher on the NYSE for the consecutive period of ten (10) trading days immediately preceding (but not including) the date of the closing of the tender offer.

F4: This amount represents 12,552 unvested restricted stock units, each of which represented a contingent right to receive one Share of Issuer. Each unvested restricted stock unit was cancelled and converted into a restricted stock unit award, with substantially the same terms and conditions (including with respect to vesting) as were applicable to such unvested restricted stock unit immediately prior to the closing of the tender offer, with respect to a number of shares of Thermo Fisher common stock equal to the product (rounded to the nearest whole share) obtained by multiplying (x) the Exchange Ratio by (y) the total number of Shares subject to the unvested restricted stock unit as of immediately prior to the closing of the tender offer.

F5: This amount represents 219,330 outstanding restricted stock unit awards in respect of Shares that were subject, in whole or in part, to vesting based on the achievement of one or more performance goals (each, a "PSU"), whether vested or unvested. Pursuant to the terms of the Purchase Agreement, 111,780 PSUs were automatically cancelled and converted into the right to receive an amount in cash (without interest and subject to required tax withholding), equal to the product of (i) $35.00 multiplied by (ii) the total number of Shares subject to such PSU award as of immediately prior to the closing of the tender offer (which, in the case of PSUs, was determined based on the actual achievement of performance conditions in accordance with the terms of the award). The remaining 107,550 PSUs were automatically cancelled and forfeited for no consideration in accordance with the terms of the Purchase Agreement and the PSU award.

F6: This amount represents ordinary shares held by Patheon Holdco Cooperatief U.A. on behalf of the reporting person. Such Shares were disposed of by Patheon Holdco Cooperatief U.A. pursuant to the tender offer for $35.00 per Share.

F7: The terms of the Option awards provide that options vest in three equal installments on each anniversary of the grant date of March 23, 2017. Options were disposed of pursuant to the Purchase Agreement, whereby each vested option was cancelled and converted into the right to receive an amount in cash, without interest, equal to the product of (x) the excess of $35.00 over the per Share exercise price of the option, multiplied by the number of Shares subject to the option upon the closing of the tender offer (rounded down to the nearest whole share). Each unvested option was cancelled and converted into a stock option award, with substantially the same terms and conditions (including with respect to vesting) as were applicable to such unvested option immediately prior to the closing of the tender offer, (i) with respect to a number of shares of Thermo Fisher common stock equal to the product (rounded down to the nearest whole share) obtained by multiplying (x) (continued in footnote 8)

F8: the Exchange Ratio by (y) the total number of Shares subject to such unvested option as of immediately prior to the closing of the tender offer and (ii) at an exercise price per share that is equal to the quotient (rounded up to the nearest cent) obtained by dividing (x) the exercise price per share of such unvested option by (y) the Exchange Ratio.

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
July 29, 2026 Filed Jul 31, 2026 21:04 UTC	IQVIA HOLDINGS INC. IQV · Entity 3058	SaleCommon Stock	5,000	$249.16	$1,245,800.00	Disclosure SEC source: 0001628280-26-051451 · wk-form4_1785531837.xml · nonDerivative · entry 1 Sherbet Eric · CIK 0001679512 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,999 Read SEC document
February 09, 2026 Filed Feb 11, 2026 22:11 UTC	IQVIA HOLDINGS INC. IQV · Entity 3058	GrantStock Appreciation Right · Derivative	12,112	$0.00 Strike: $192.67	$0.00	Disclosure SEC source: 0001628280-26-007357 · wk-form4_1770847877.xml · derivative · entry 1 Sherbet Eric · CIK 0001679512 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,112 Underlying: Common Stock · 12,112 shares Expires 2036-02-09 F1 · derivative.exercise_date: This stock appreciation right vests in three annual installments beginning on February 9, 2027. Read SEC document
February 08, 2026 Filed Feb 10, 2026 22:49 UTC	IQVIA HOLDINGS INC. IQV · Entity 3058	Tax withholdingCommon Stock	1,915	$187.49	$359,043.35	Disclosure SEC source: 0001628280-26-006963 · wk-form4_1770763788.xml · nonDerivative · entry 2 Sherbet Eric · CIK 0001679512 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,999 Read SEC document
February 08, 2026 Filed Feb 10, 2026 22:49 UTC	IQVIA HOLDINGS INC. IQV · Entity 3058	GrantCommon Stock	6,806	$0.00	$0.00	Disclosure SEC source: 0001628280-26-006963 · wk-form4_1770763788.xml · nonDerivative · entry 1 Sherbet Eric · CIK 0001679512 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,914 F1 · shares: Acquired upon achievement of certain performance criteria pursuant to the performance-based restricted stock units granted on February 13, 2023. The performance conditions applicable to the award were determined to have been satisfied by the Company's Leadership Development and Compensation Committee on February 8, 2026. Read SEC document
October 29, 2025 Filed Oct 31, 2025 21:01 UTC	IQVIA HOLDINGS INC. IQV · Entity 3058	Exercise / conversionStock Appreciation Right · Derivative	10,000	$131.82 Strike: $131.82	$1,318,200.00	Disclosure SEC source: 0001679512-25-000006 · wk-form4_1761944488.xml · derivative · entry 4 Sherbet Eric · CIK 0001679512 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,436 Underlying: Common Stock · 10,000 shares Expires 2029-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
October 29, 2025 Filed Oct 31, 2025 21:01 UTC	IQVIA HOLDINGS INC. IQV · Entity 3058	Disposition to issuerCommon Stock	6,000	$219.72	$1,318,320.00	Disclosure SEC source: 0001679512-25-000006 · wk-form4_1761944488.xml · nonDerivative · entry 3 Sherbet Eric · CIK 0001679512 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,108 Read SEC document
October 29, 2025 Filed Oct 31, 2025 21:01 UTC	IQVIA HOLDINGS INC. IQV · Entity 3058	SaleCommon Stock	4,000	$219.70	$878,800.00	Disclosure SEC source: 0001679512-25-000006 · wk-form4_1761944488.xml · nonDerivative · entry 2 Sherbet Eric · CIK 0001679512 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,108 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $219.66 to $219.92, inclusive. Read SEC document
October 29, 2025 Filed Oct 31, 2025 21:01 UTC	IQVIA HOLDINGS INC. IQV · Entity 3058	Exercise / conversionCommon Stock	10,000	$131.82	$1,318,200.00	Disclosure SEC source: 0001679512-25-000006 · wk-form4_1761944488.xml · nonDerivative · entry 1 Sherbet Eric · CIK 0001679512 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,108 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
July 23, 2025 Filed Jul 25, 2025 21:00 UTC	IQVIA HOLDINGS INC. IQV · Entity 3058	Exercise / conversionStock Appreciation Right · Derivative	11,870	$97.20 Strike: $97.20	$1,153,764.00	Disclosure SEC source: 0001478242-25-000109 · wk-form4_1753477250.xml · derivative · entry 4 Sherbet Eric · CIK 0001679512 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 11,870 shares Expires 2028-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
July 23, 2025 Filed Jul 25, 2025 21:00 UTC	IQVIA HOLDINGS INC. IQV · Entity 3058	Disposition to issuerCommon Stock	6,070	$190.10	$1,153,907.00	Disclosure SEC source: 0001478242-25-000109 · wk-form4_1753477250.xml · nonDerivative · entry 3 Sherbet Eric · CIK 0001679512 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,108 Read SEC document
July 23, 2025 Filed Jul 25, 2025 21:00 UTC	IQVIA HOLDINGS INC. IQV · Entity 3058	SaleCommon Stock	5,800	$190.05	$1,102,290.00	Disclosure SEC source: 0001478242-25-000109 · wk-form4_1753477250.xml · nonDerivative · entry 2 Sherbet Eric · CIK 0001679512 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,178 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $189.99 to $190.18, inclusive. Read SEC document
July 23, 2025 Filed Jul 25, 2025 21:00 UTC	IQVIA HOLDINGS INC. IQV · Entity 3058	Exercise / conversionCommon Stock	11,870	$97.20	$1,153,764.00	Disclosure SEC source: 0001478242-25-000109 · wk-form4_1753477250.xml · nonDerivative · entry 1 Sherbet Eric · CIK 0001679512 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,978 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
February 10, 2025 Filed Feb 12, 2025 22:14 UTC	IQVIA HOLDINGS INC. IQV · Entity 3058	Tax withholdingCommon Stock	179	$206.97	$37,047.63	Disclosure SEC source: 0001478242-25-000040 · wk-form4_1739398438.xml · nonDerivative · entry 1 Sherbet Eric · CIK 0001679512 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,108 Read SEC document
January 28, 2025 Filed Jan 30, 2025 22:55 UTC	IQVIA HOLDINGS INC. IQV · Entity 3058	GrantStock Appreciation Right · Derivative	14,045	$0.00 Strike: $203.43	$0.00	Disclosure SEC source: 0001478242-25-000009 · wk-form4_1738277750.xml · derivative · entry 3 Sherbet Eric · CIK 0001679512 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,045 Underlying: Common Stock · 14,045 shares Expires 2035-01-28 F2 · derivative.exercise_date: This stock appreciation right vests in three annual installments beginning on January 28, 2026. Read SEC document
January 28, 2025 Filed Jan 30, 2025 22:55 UTC	IQVIA HOLDINGS INC. IQV · Entity 3058	Tax withholdingCommon Stock	605	$203.43	$123,075.15	Disclosure SEC source: 0001478242-25-000009 · wk-form4_1738277750.xml · nonDerivative · entry 2 Sherbet Eric · CIK 0001679512 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,287 Read SEC document
January 28, 2025 Filed Jan 30, 2025 22:55 UTC	IQVIA HOLDINGS INC. IQV · Entity 3058	GrantCommon Stock	2,356	$0.00	$0.00	Disclosure SEC source: 0001478242-25-000009 · wk-form4_1738277750.xml · nonDerivative · entry 1 Sherbet Eric · CIK 0001679512 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,892 F1 · shares: Acquired upon achievement of certain performance criteria pursuant to the performance-based restricted stock units granted on February 10, 2022. The performance conditions applicable to the award were determined to have been satisfied by the Company's Leadership Development and Compensation Committee on January 28, 2025. Read SEC document
August 27, 2024 Filed Aug 29, 2024 21:02 UTC	IQVIA HOLDINGS INC. IQV · Entity 3058	SaleCommon Stock	1,300	$246.33	$320,229.00	Disclosure SEC source: 0001478242-24-000107 · wk-form4_1724965363.xml · nonDerivative · entry 1 Sherbet Eric · CIK 0001679512 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,536 Read SEC document
February 16, 2024 Filed Feb 21, 2024 22:08 UTC	IQVIA HOLDINGS INC. IQV · Entity 3058	SaleCommon Stock	1,000	$241.50	$241,500.00	Disclosure SEC source: 0001478242-24-000048 · wk-form4_1708553297.xml · nonDerivative · entry 1 Sherbet Eric · CIK 0001679512 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,836 Read SEC document
February 10, 2024 Filed Feb 13, 2024 22:11 UTC	IQVIA HOLDINGS INC. IQV · Entity 3058	Tax withholdingCommon Stock	289	$218.20	$63,059.80	Disclosure SEC source: 0001478242-24-000030 · wk-form4_1707862236.xml · nonDerivative · entry 2 Sherbet Eric · CIK 0001679512 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,836 Read SEC document
February 09, 2024 Filed Feb 13, 2024 22:11 UTC	IQVIA HOLDINGS INC. IQV · Entity 3058	Tax withholdingCommon Stock	281	$218.20	$61,314.20	Disclosure SEC source: 0001478242-24-000030 · wk-form4_1707862236.xml · nonDerivative · entry 1 Sherbet Eric · CIK 0001679512 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,125 Read SEC document
February 07, 2024 Filed Feb 8, 2024 22:17 UTC	IQVIA HOLDINGS INC. IQV · Entity 3058	GrantStock Appreciation Right · Derivative	9,496	$0.00 Strike: $214.34	$0.00	Disclosure SEC source: 0001478242-24-000013 · wk-form4_1707430610.xml · derivative · entry 3 Sherbet Eric · CIK 0001679512 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,496 Underlying: Common Stock · 9,496 shares Expires 2034-02-07 F2 · derivative.exercise_date: The stock appreciation right vests in three annual installments beginning on February 7, 2025. Read SEC document
February 06, 2024 Filed Feb 8, 2024 22:17 UTC	IQVIA HOLDINGS INC. IQV · Entity 3058	Tax withholdingCommon Stock	2,372	$215.41	$510,952.52	Disclosure SEC source: 0001478242-24-000013 · wk-form4_1707430610.xml · nonDerivative · entry 2 Sherbet Eric · CIK 0001679512 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,406 Read SEC document
February 06, 2024 Filed Feb 8, 2024 22:17 UTC	IQVIA HOLDINGS INC. IQV · Entity 3058	GrantCommon Stock	7,725	$0.00	$0.00	Disclosure SEC source: 0001478242-24-000013 · wk-form4_1707430610.xml · nonDerivative · entry 1 Sherbet Eric · CIK 0001679512 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,778 F1 · shares: Acquired upon achievement of certain performance criteria pursuant to the performance-based restricted stock units granted on February 9, 2021. The performance conditions applicable to the award were determined to have been satisfied by the Company's Leadership Development and Compensation Committee on February 6, 2024. Read SEC document
February 14, 2023 Filed Feb 15, 2023 22:58 UTC	IQVIA HOLDINGS INC. IQV · Entity 3058	SaleCommon Stock	1,000	$230.00	$230,000.00	Disclosure SEC source: 0001478242-23-000045 · wf-form4_167650191070248.xml · nonDerivative · entry 1 Sherbet Eric · CIK 0001679512 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,053 Read SEC document
February 13, 2023 Filed Feb 15, 2023 22:58 UTC	IQVIA HOLDINGS INC. IQV · Entity 3058	GrantStock Appreciation Right · Derivative	8,583	$0.00 Strike: $232.11	$0.00	Disclosure SEC source: 0001478242-23-000045 · wf-form4_167650191070248.xml · derivative · entry 2 Sherbet Eric · CIK 0001679512 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,583 Underlying: Common Stock · 8,583 shares Expires 2033-02-13 F1 · derivative.exercise_date: The stock appreciation right vests in three annual installments beginning on February 13, 2024. Read SEC document
February 10, 2023 Filed Feb 13, 2023 22:05 UTC	IQVIA HOLDINGS INC. IQV · Entity 3058	Tax withholdingCommon Stock	326	$222.84	$72,645.84	Disclosure SEC source: 0001478242-23-000029 · wf-form4_167632590634307.xml · nonDerivative · entry 2 Sherbet Eric · CIK 0001679512 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,053 Read SEC document
February 09, 2023 Filed Feb 13, 2023 22:05 UTC	IQVIA HOLDINGS INC. IQV · Entity 3058	Tax withholdingCommon Stock	317	$230.31	$73,008.27	Disclosure SEC source: 0001478242-23-000029 · wf-form4_167632590634307.xml · nonDerivative · entry 1 Sherbet Eric · CIK 0001679512 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,379 Read SEC document
February 07, 2023 Filed Feb 9, 2023 22:25 UTC	IQVIA HOLDINGS INC. IQV · Entity 3058	Tax withholdingCommon Stock	3,267	$235.84	$770,489.28	Disclosure SEC source: 0001478242-23-000015 · wf-form4_167598149206274.xml · nonDerivative · entry 2 Sherbet Eric · CIK 0001679512 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,696 Read SEC document
February 07, 2023 Filed Feb 9, 2023 22:25 UTC	IQVIA HOLDINGS INC. IQV · Entity 3058	GrantCommon Stock	8,745	$0.00	$0.00	Disclosure SEC source: 0001478242-23-000015 · wf-form4_167598149206274.xml · nonDerivative · entry 1 Sherbet Eric · CIK 0001679512 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,963 F1 · shares: Acquired upon achievement of certain performance criteria pursuant to the performance-based restricted stock units granted on February 11, 2020. The performance conditions applicable to the award were determined to have been satisfied by the Company's Leadership Development and Compensation Committee on February 7, 2023. Read SEC document
February 10, 2022 Filed Feb 14, 2022 22:08 UTC	IQVIA HOLDINGS INC. IQV · Entity 3058	GrantStock Appreciation Right · Derivative	8,193	$0.00 Strike: $250.43	$0.00	Disclosure SEC source: 0001478242-22-000026 · wf-form4_164487650328594.xml · derivative · entry 2 Sherbet Eric · CIK 0001679512 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,193 Underlying: Common Stock · 8,193 shares Expires 2032-02-10 F2 · derivative.exercise_date: The stock appreciation right vests in three annual installments beginning on February 10, 2023. Read SEC document
February 10, 2022 Filed Feb 14, 2022 22:08 UTC	IQVIA HOLDINGS INC. IQV · Entity 3058	GrantCommon Stock	2,200	$0.00	$0.00	Disclosure SEC source: 0001478242-22-000026 · wf-form4_164487650328594.xml · nonDerivative · entry 1 Sherbet Eric · CIK 0001679512 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,218 F1 · shares: Represents a grant of restricted stock units that will vest in three annual installments beginning on February 10, 2023. Read SEC document
February 09, 2022 Filed Feb 11, 2022 22:04 UTC	IQVIA HOLDINGS INC. IQV · Entity 3058	Tax withholdingCommon Stock	3,788	$255.57	$968,099.16	Disclosure SEC source: 0001478242-22-000015 · wf-form4_164461703666535.xml · nonDerivative · entry 2 Sherbet Eric · CIK 0001679512 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,018 Read SEC document
February 09, 2022 Filed Feb 11, 2022 22:04 UTC	IQVIA HOLDINGS INC. IQV · Entity 3058	GrantCommon Stock	9,114	$0.00	$0.00	Disclosure SEC source: 0001478242-22-000015 · wf-form4_164461703666535.xml · nonDerivative · entry 1 Sherbet Eric · CIK 0001679512 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,806 F1 · shares: Acquired upon achievement of certain performance criteria pursuant to the performance-based restricted stock units granted on February 13, 2019. The performance conditions applicable to the award were determined to have been satisfied by the Company's Leadership Development and Compensation Committee on February 9, 2022. Read SEC document
February 09, 2021 Filed Feb 11, 2021 22:20 UTC	IQVIA HOLDINGS INC. IQV · Entity 3058	GrantStock Appreciation Right · Derivative	8,544	$0.00 Strike: $183.82	$0.00	Disclosure SEC source: 0001478242-21-000010 · wf-form4_161308203651366.xml · derivative · entry 4 Sherbet Eric · CIK 0001679512 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,544 Underlying: Common Stock · 8,544 shares Expires 2031-02-09 F3 · derivative.exercise_date: This stock appreciation right vests in three annual installments beginning on February 9, 2022. Read SEC document
February 09, 2021 Filed Feb 11, 2021 22:20 UTC	IQVIA HOLDINGS INC. IQV · Entity 3058	Tax withholdingCommon Stock	1,893	$183.82	$347,971.26	Disclosure SEC source: 0001478242-21-000010 · wf-form4_161308203651366.xml · nonDerivative · entry 3 Sherbet Eric · CIK 0001679512 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,692 Read SEC document
February 09, 2021 Filed Feb 11, 2021 22:20 UTC	IQVIA HOLDINGS INC. IQV · Entity 3058	GrantCommon Stock	2,140	$0.00	$0.00	Disclosure SEC source: 0001478242-21-000010 · wf-form4_161308203651366.xml · nonDerivative · entry 2 Sherbet Eric · CIK 0001679512 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,585 F2 · shares: Represents a grant of restricted stock units that will vest in three annual installments beginning on February 9, 2022. Read SEC document
February 09, 2021 Filed Feb 11, 2021 22:20 UTC	IQVIA HOLDINGS INC. IQV · Entity 3058	GrantCommon Stock	5,445	$0.00	$0.00	Disclosure SEC source: 0001478242-21-000010 · wf-form4_161308203651366.xml · nonDerivative · entry 1 Sherbet Eric · CIK 0001679512 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,445 F1 · shares: Acquired upon achievement of certain performance criteria pursuant to the performance-based restricted stock units granted on February 8, 2018. The performance conditions applicable to the award were determined to have been satisfied by the Company's Leadership Development and Compensation Committee on February 9, 2021. Read SEC document
February 11, 2020 Filed Feb 13, 2020 22:07 UTC	IQVIA HOLDINGS INC. IQV · Entity 3058	GrantStock Appreciation Right · Derivative	22,404	$0.00 Strike: $161.70	$0.00	Disclosure SEC source: 0001478242-20-000009 · edgar.xml · derivative · entry 1 Sherbet Eric · CIK 0001679512 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,404 Underlying: Common Stock · 22,404 shares Expires 2030-02-11 F1 · derivative.exercise_date: This stock appreciation right vests in three annual installments beginning on February 11, 2021. Read SEC document
February 13, 2019 Filed Feb 15, 2019 22:07 UTC	IQVIA HOLDINGS INC. IQV · Entity 3058	GrantStock Appreciation Right · Derivative	18,436	$0.00 Strike: $131.82	$0.00	Disclosure SEC source: 0001478242-19-000008 · edgar.xml · derivative · entry 1 Sherbet Eric · CIK 0001679512 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,436 Underlying: Common Stock · 18,436 shares Expires 2029-02-13 F1 · derivative.exercise_date: This stock appreciation right vests in three annual installments beginning on 02/13/2020. Read SEC document
March 01, 2018 Filed Mar 5, 2018 21:43 UTC	IQVIA HOLDINGS INC. IQV · Entity 3058	GrantStock Appreciation Right · Derivative	11,870	$0.00 Strike: $97.20	$0.00	Disclosure SEC source: 0001478242-18-000019 · edgar.xml · derivative · entry 1 Sherbet Eric · CIK 0001679512 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,870 Underlying: Common Stock · 11,870 shares Expires 2028-03-01 F1 · derivative.exercise_date: This stock appreciation right vests in three annual installments beginning on 03/01/2019. Read SEC document
August 29, 2017 Filed Aug 31, 2017 18:27 UTC	Patheon N.V. PTHN · Entity 173467	Disposition to issuerOptions (Right to Buy) · Derivative	32,630	Not disclosed Strike: $26.49	Not disclosed	Disclosure SEC source: 0001209191-17-050946 · doc4.xml · derivative · entry 4 Sherbet Eric · CIK 0001679512 · General Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 32,630 shares Expires not disclosed F7 · price: The terms of the Option awards provide that options vest in three equal installments on each anniversary of the grant date of March 23, 2017. Options were disposed of pursuant to the Purchase Agreement, whereby each vested option was cancelled and converted into the right to receive an amount in cash, without interest, equal to the product of (x) the excess of $35.00 over the per Share exercise price of the option, multiplied by the number of Shares subject to the option upon the closing of the tender offer (rounded down to the nearest whole share). Each unvested option was cancelled and converted into a stock option award, with substantially the same terms and conditions (including with respect to vesting) as were applicable to such unvested option immediately prior to the closing of the tender offer, (i) with respect to a number of shares of Thermo Fisher common stock equal to the product (rounded down to the nearest whole share) obtained by multiplying (x) (continued in footnote 8) F8 · price: the Exchange Ratio by (y) the total number of Shares subject to such unvested option as of immediately prior to the closing of the tender offer and (ii) at an exercise price per share that is equal to the quotient (rounded up to the nearest cent) obtained by dividing (x) the exercise price per share of such unvested option by (y) the Exchange Ratio. F7 · derivative.exercise_date: The terms of the Option awards provide that options vest in three equal installments on each anniversary of the grant date of March 23, 2017. Options were disposed of pursuant to the Purchase Agreement, whereby each vested option was cancelled and converted into the right to receive an amount in cash, without interest, equal to the product of (x) the excess of $35.00 over the per Share exercise price of the option, multiplied by the number of Shares subject to the option upon the closing of the tender offer (rounded down to the nearest whole share). Each unvested option was cancelled and converted into a stock option award, with substantially the same terms and conditions (including with respect to vesting) as were applicable to such unvested option immediately prior to the closing of the tender offer, (i) with respect to a number of shares of Thermo Fisher common stock equal to the product (rounded down to the nearest whole share) obtained by multiplying (x) (continued in footnote 8) F8 · derivative.exercise_date: the Exchange Ratio by (y) the total number of Shares subject to such unvested option as of immediately prior to the closing of the tender offer and (ii) at an exercise price per share that is equal to the quotient (rounded up to the nearest cent) obtained by dividing (x) the exercise price per share of such unvested option by (y) the Exchange Ratio. F7 · derivative.expiration_date: The terms of the Option awards provide that options vest in three equal installments on each anniversary of the grant date of March 23, 2017. Options were disposed of pursuant to the Purchase Agreement, whereby each vested option was cancelled and converted into the right to receive an amount in cash, without interest, equal to the product of (x) the excess of $35.00 over the per Share exercise price of the option, multiplied by the number of Shares subject to the option upon the closing of the tender offer (rounded down to the nearest whole share). Each unvested option was cancelled and converted into a stock option award, with substantially the same terms and conditions (including with respect to vesting) as were applicable to such unvested option immediately prior to the closing of the tender offer, (i) with respect to a number of shares of Thermo Fisher common stock equal to the product (rounded down to the nearest whole share) obtained by multiplying (x) (continued in footnote 8) F8 · derivative.expiration_date: the Exchange Ratio by (y) the total number of Shares subject to such unvested option as of immediately prior to the closing of the tender offer and (ii) at an exercise price per share that is equal to the quotient (rounded up to the nearest cent) obtained by dividing (x) the exercise price per share of such unvested option by (y) the Exchange Ratio. Read SEC document
August 29, 2017 Filed Aug 31, 2017 18:27 UTC	Patheon N.V. PTHN · Entity 173467	OtherOrdinary Shares	129,595	$35.00	$4,535,825.00	Disclosure SEC source: 0001209191-17-050946 · doc4.xml · nonDerivative · entry 3 Sherbet Eric · CIK 0001679512 · General Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Indirect · By Patheon Holdco Cooperatief U.A. on behalf of the reporting person Disclosed balance after: 0 F1 · kind: Ordinary shares of Patheon N.V. ("Issuer") were disposed of pursuant to a tender offer by Thermo Fisher (CN) Luxembourg S.a r.l., a private limited liability company (societe a responsabilite limitee) organized under the laws of the Grand Duchy of Luxembourg ("Purchaser") and Thermo Fisher Scientific Inc., a Delaware corporation ("Thermo Fisher"), to acquire all of the issued and outstanding ordinary shares (the "Shares") of Issuer at a purchase price of $35.00 per Share, pursuant to the terms of the Purchase Agreement, dated as of May 15, 2017 (as it may be amended from time to time, the "Purchase Agreement"), by and between Issuer, Purchaser and Thermo Fisher. Pursuant to the terms of the Purchase Agreement, each vested restricted stock unit was cancelled and converted into the right to receive an amount in cash, without interest, equal to the product obtained by multiplying $35.00 by the total number of Shares subject to the restricted stock unit (continued in footnote 2) F2 · kind: upon the closing of the tender offer (with restricted stock units that are subject to performance conditions vesting based on achievement of actual performance conditions in accordance with the terms of the award). Each unvested restricted stock unit was cancelled and converted into a restricted stock unit award, with substantially the same terms and conditions (including with respect to vesting) as were applicable to such unvested restricted stock unit immediately prior to the closing of the tender offer, with respect to a number of shares of Thermo Fisher common stock equal to the product (rounded to the nearest whole share) obtained by multiplying (x) the Exchange Ratio by (y) the total number of Shares subject to the unvested restricted stock unit as of immediately prior to the closing of the tender offer. (continued in footnote 3) F3 · kind: The "Exchange Ratio" is 0.1996919, which represents the quotient obtained by dividing (i) $35.00 by (ii) the average closing price, rounded to the nearest cent, per share of common stock of Thermo Fisher on the NYSE for the consecutive period of ten (10) trading days immediately preceding (but not including) the date of the closing of the tender offer. F6 · shares: This amount represents ordinary shares held by Patheon Holdco Cooperatief U.A. on behalf of the reporting person. Such Shares were disposed of by Patheon Holdco Cooperatief U.A. pursuant to the tender offer for $35.00 per Share. Read SEC document
August 29, 2017 Filed Aug 31, 2017 18:27 UTC	Patheon N.V. PTHN · Entity 173467	OtherRestricted Stock Units (Ordinary Shares)	219,330	Not disclosed	Not disclosed	Disclosure SEC source: 0001209191-17-050946 · doc4.xml · nonDerivative · entry 2 Sherbet Eric · CIK 0001679512 · General Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F5 · kind: This amount represents 219,330 outstanding restricted stock unit awards in respect of Shares that were subject, in whole or in part, to vesting based on the achievement of one or more performance goals (each, a "PSU"), whether vested or unvested. Pursuant to the terms of the Purchase Agreement, 111,780 PSUs were automatically cancelled and converted into the right to receive an amount in cash (without interest and subject to required tax withholding), equal to the product of (i) $35.00 multiplied by (ii) the total number of Shares subject to such PSU award as of immediately prior to the closing of the tender offer (which, in the case of PSUs, was determined based on the actual achievement of performance conditions in accordance with the terms of the award). The remaining 107,550 PSUs were automatically cancelled and forfeited for no consideration in accordance with the terms of the Purchase Agreement and the PSU award. F5 · shares: This amount represents 219,330 outstanding restricted stock unit awards in respect of Shares that were subject, in whole or in part, to vesting based on the achievement of one or more performance goals (each, a "PSU"), whether vested or unvested. Pursuant to the terms of the Purchase Agreement, 111,780 PSUs were automatically cancelled and converted into the right to receive an amount in cash (without interest and subject to required tax withholding), equal to the product of (i) $35.00 multiplied by (ii) the total number of Shares subject to such PSU award as of immediately prior to the closing of the tender offer (which, in the case of PSUs, was determined based on the actual achievement of performance conditions in accordance with the terms of the award). The remaining 107,550 PSUs were automatically cancelled and forfeited for no consideration in accordance with the terms of the Purchase Agreement and the PSU award. F5 · price: This amount represents 219,330 outstanding restricted stock unit awards in respect of Shares that were subject, in whole or in part, to vesting based on the achievement of one or more performance goals (each, a "PSU"), whether vested or unvested. Pursuant to the terms of the Purchase Agreement, 111,780 PSUs were automatically cancelled and converted into the right to receive an amount in cash (without interest and subject to required tax withholding), equal to the product of (i) $35.00 multiplied by (ii) the total number of Shares subject to such PSU award as of immediately prior to the closing of the tender offer (which, in the case of PSUs, was determined based on the actual achievement of performance conditions in accordance with the terms of the award). The remaining 107,550 PSUs were automatically cancelled and forfeited for no consideration in accordance with the terms of the Purchase Agreement and the PSU award. Read SEC document
August 29, 2017 Filed Aug 31, 2017 18:27 UTC	Patheon N.V. PTHN · Entity 173467	OtherRestricted Stock Units (Ordinary Shares)	12,552	Not disclosed	Not disclosed	Disclosure SEC source: 0001209191-17-050946 · doc4.xml · nonDerivative · entry 1 Sherbet Eric · CIK 0001679512 · General Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 219,330 F1 · kind: Ordinary shares of Patheon N.V. ("Issuer") were disposed of pursuant to a tender offer by Thermo Fisher (CN) Luxembourg S.a r.l., a private limited liability company (societe a responsabilite limitee) organized under the laws of the Grand Duchy of Luxembourg ("Purchaser") and Thermo Fisher Scientific Inc., a Delaware corporation ("Thermo Fisher"), to acquire all of the issued and outstanding ordinary shares (the "Shares") of Issuer at a purchase price of $35.00 per Share, pursuant to the terms of the Purchase Agreement, dated as of May 15, 2017 (as it may be amended from time to time, the "Purchase Agreement"), by and between Issuer, Purchaser and Thermo Fisher. Pursuant to the terms of the Purchase Agreement, each vested restricted stock unit was cancelled and converted into the right to receive an amount in cash, without interest, equal to the product obtained by multiplying $35.00 by the total number of Shares subject to the restricted stock unit (continued in footnote 2) F2 · kind: upon the closing of the tender offer (with restricted stock units that are subject to performance conditions vesting based on achievement of actual performance conditions in accordance with the terms of the award). Each unvested restricted stock unit was cancelled and converted into a restricted stock unit award, with substantially the same terms and conditions (including with respect to vesting) as were applicable to such unvested restricted stock unit immediately prior to the closing of the tender offer, with respect to a number of shares of Thermo Fisher common stock equal to the product (rounded to the nearest whole share) obtained by multiplying (x) the Exchange Ratio by (y) the total number of Shares subject to the unvested restricted stock unit as of immediately prior to the closing of the tender offer. (continued in footnote 3) F3 · kind: The "Exchange Ratio" is 0.1996919, which represents the quotient obtained by dividing (i) $35.00 by (ii) the average closing price, rounded to the nearest cent, per share of common stock of Thermo Fisher on the NYSE for the consecutive period of ten (10) trading days immediately preceding (but not including) the date of the closing of the tender offer. F4 · shares: This amount represents 12,552 unvested restricted stock units, each of which represented a contingent right to receive one Share of Issuer. Each unvested restricted stock unit was cancelled and converted into a restricted stock unit award, with substantially the same terms and conditions (including with respect to vesting) as were applicable to such unvested restricted stock unit immediately prior to the closing of the tender offer, with respect to a number of shares of Thermo Fisher common stock equal to the product (rounded to the nearest whole share) obtained by multiplying (x) the Exchange Ratio by (y) the total number of Shares subject to the unvested restricted stock unit as of immediately prior to the closing of the tender offer. F1 · price: Ordinary shares of Patheon N.V. ("Issuer") were disposed of pursuant to a tender offer by Thermo Fisher (CN) Luxembourg S.a r.l., a private limited liability company (societe a responsabilite limitee) organized under the laws of the Grand Duchy of Luxembourg ("Purchaser") and Thermo Fisher Scientific Inc., a Delaware corporation ("Thermo Fisher"), to acquire all of the issued and outstanding ordinary shares (the "Shares") of Issuer at a purchase price of $35.00 per Share, pursuant to the terms of the Purchase Agreement, dated as of May 15, 2017 (as it may be amended from time to time, the "Purchase Agreement"), by and between Issuer, Purchaser and Thermo Fisher. Pursuant to the terms of the Purchase Agreement, each vested restricted stock unit was cancelled and converted into the right to receive an amount in cash, without interest, equal to the product obtained by multiplying $35.00 by the total number of Shares subject to the restricted stock unit (continued in footnote 2) F2 · price: upon the closing of the tender offer (with restricted stock units that are subject to performance conditions vesting based on achievement of actual performance conditions in accordance with the terms of the award). Each unvested restricted stock unit was cancelled and converted into a restricted stock unit award, with substantially the same terms and conditions (including with respect to vesting) as were applicable to such unvested restricted stock unit immediately prior to the closing of the tender offer, with respect to a number of shares of Thermo Fisher common stock equal to the product (rounded to the nearest whole share) obtained by multiplying (x) the Exchange Ratio by (y) the total number of Shares subject to the unvested restricted stock unit as of immediately prior to the closing of the tender offer. (continued in footnote 3) F3 · price: The "Exchange Ratio" is 0.1996919, which represents the quotient obtained by dividing (i) $35.00 by (ii) the average closing price, rounded to the nearest cent, per share of common stock of Thermo Fisher on the NYSE for the consecutive period of ten (10) trading days immediately preceding (but not including) the date of the closing of the tender offer. Read SEC document
March 23, 2017 Filed Mar 27, 2017 15:12 UTC	Patheon N.V. PTHN · Entity 173467	GrantOptions (Right to Buy) · Derivative	32,630	$0.00 Strike: $26.49	$0.00	Disclosure SEC source: 0001679512-17-000002 · wf-form4_149064191708736.xml · derivative · entry 2 Sherbet Eric · CIK 0001679512 · General Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,630 Underlying: Options (Right to Buy) · 32,630 shares Expires not disclosed F2 · derivative.exercise_date: The options vest in three equal installments on each anniversary of the grant date of March 23, 2017. F2 · derivative.expiration_date: The options vest in three equal installments on each anniversary of the grant date of March 23, 2017. Read SEC document
March 23, 2017 Filed Mar 27, 2017 15:12 UTC	Patheon N.V. PTHN · Entity 173467	GrantRestricted Stock Units (Ordinary Shares)	12,552	$0.00	$0.00	Disclosure SEC source: 0001679512-17-000002 · wf-form4_149064191708736.xml · nonDerivative · entry 1 Sherbet Eric · CIK 0001679512 · General Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 231,882 F1 · shares: The restricted stock units vest in three equal installments on each anniversary of the grant date of March 23, 2017. Each restricted stock unit represents a contingent right to receive one ordinary share. Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.